Skip to content
10-Q

Quarterly Report

Adhera Therapeutics, Inc.

0001493152-23-042138

← back to feed
Filed
Nov 20, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 20, 2023 7.22M sh
Shares Diluted Q3 2023 · Sep 30, 2023 4.3M sh
Shares Diluted Q3 2023 · Sep 30, 2023 3.65M sh
Shares Diluted Q3 2023 · Sep 30, 2022 3.16M sh
Shares Diluted Q3 2023 · Sep 30, 2022 2.02M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$655.16K
Operating Cash Flow restated Q3 2023 · Sep 30, 2022 −$1.36M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$26.32M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$22.79M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$23.09M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$22.19M
Stockholders Equity restated Q3 2023 · Sep 30, 2022 −$21.81M
Stockholders Equity restated Q3 2023 · Jun 30, 2022 −$19.99M
Stockholders Equity restated Q3 2023 · Mar 31, 2022 −$25.5M
Stockholders Equity restated Q3 2023 · Dec 31, 2021 −$25.11M
Current Liabilities Q3 2023 · Sep 30, 2023 $26.36M
Current Liabilities Q3 2023 · Dec 31, 2022 $22.26M
Total Liabilities Q3 2023 · Sep 30, 2023 $26.36M
Total Liabilities Q3 2023 · Dec 31, 2022 $22.26M
Current Assets Q3 2023 · Sep 30, 2023 $44.07K
Current Assets Q3 2023 · Dec 31, 2022 $78.51K
Total Assets Q3 2023 · Sep 30, 2023 $44.07K
Total Assets Q3 2023 · Dec 31, 2022 $78.51K
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.83
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.16
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.57
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.17
Eps Basic Q3 2023 · Sep 30, 2023 −$0.83
Eps Basic Q3 2023 · Sep 30, 2023 −$1.16
Eps Basic Q3 2023 · Sep 30, 2022 −$0.57
Eps Basic restated Q3 2023 · Sep 30, 2022 −$1.17
Net Income Q3 2023 · Sep 30, 2023 −$3.54M
Net Income Q3 2023 · Sep 30, 2023 −$4.15M
Net Income Q3 2023 · Jun 30, 2023 $271.28K
Net Income Q3 2023 · Mar 31, 2023 −$885.84K
Net Income restated Q3 2023 · Sep 30, 2022 −$1.8M
Net Income restated Q3 2023 · Sep 30, 2022 −$1.78M
Net Income restated Q3 2023 · Jun 30, 2022 $98.29K
Net Income restated Q3 2023 · Mar 31, 2022 −$73.73K
Operating Income Q3 2023 · Sep 30, 2023 −$269.5K
Operating Income Q3 2023 · Sep 30, 2023 −$917.52K
Operating Income restated Q3 2023 · Sep 30, 2022 −$547.57K
Operating Income restated Q3 2023 · Sep 30, 2022 −$1.26M